Omega-3 Fatty Acids and Mood, Made Practical

The neuroinflammatory link, the EPA vs. DHA distinction, and what supplementation can and cannot do

Do omega-3 fatty acids actually improve mood and reduce anxiety?

Meta-analyses of randomized trials find a moderate antidepressant effect for omega-3 supplementation, strongest for EPA-dominant formulas in people with diagnosed depression. Effects in subclinical low mood and anxiety are smaller and less consistent. The mechanism — EPA and DHA incorporation into neuronal membranes and modulation of inflammatory and neurotransmitter pathways — is well characterized. Supplementation is not a substitute for treatment, but correcting a genuine dietary deficiency has real and measurable effects.

John Hibbeln’s epidemiological work at the NIH showed that countries with high seafood consumption have markedly lower rates of depression — one of the earliest large-scale signals linking omega-3 fatty acids to mental health. Subsequent clinical work found that EPA, more than DHA, drives antidepressant effects. The mechanism involves membrane fluidity, neuroinflammation, and neurotransmitter receptor function. Below are the practices that translate this evidence into daily decisions, with honest calibration of where the science is strong and where it is not.